ORIC Pharmaceuticals, Inc. (ORIC) Tops Q3 EPS by 2c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.44), $0.02 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Ingram Micro Holding Corporation (INGM) Tops Q2 EPS by 4c
• Minerals Technologies (MTX) Misses Q2 EPS by 3c
• Corteva (CTVA) Tops Q2 EPS by 8c; offers guidance